TRENDING :  Market Movers  |  Top 50   FDX (-2.8%)    SPY (-1.93%)    AMZN (-3%)    VXXB (11.47%)    WYNN (-3.5%)    XLE (-2.71%)    XLF (-2.77%)    XLU (0.73%)    XRX (-5.6%)    ZUO (-14.06%)    BA (-2.83%)    BAC (-4.16%)    BIIB (-4.49%)    BPTH (18.94%)    CFMS (-1.65%)    CHKP (-0.58%)    CLRB (-6.1%)    CSIQ (-2.75%)    CVRS (2.72%)    CZZ (-7.45%)    DIS (-0.4%)    EVRI (-1.11%)    SQ (-4.39%)    TAC (-1.18%)    TARO (-0.12%)

 IMGN - ImmunoGen

$2.41 [-0.16][-6.23%]

Next Earnings

5/3/2019

BMO

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

3


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $3.50
Low $3.50
Average $3.50
Current $2.41

CompanyAnalyst NamePT ActionActionRatingTargetDate
H.C. WainwrightDebjit ChattopadhyayLowersDowngradesHold$3.5003/04/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $IMGN

TRENDING ARTICLES



Options Traders Expect Huge Moves in ImmunoGen (IMGN) Stock

03/12/19
Investors in ImmunoGen Inc IMGN need to pay close attention to the stock based on moves in the options market lately That is because the Mar 3 2019 3 00 Call had some of the highest implied volatility of all equity options today What is Implied Volatility Implied volatility

ImmunoGen (IMGN) Down 50.2% Since Last Earnings Report: Can It Rebound?

03/10/19
It has been about a month since the las t earnings report for ImmunoGen IMGN Shares have lost about 50 2 in that time frame underperforming the S amp P 500 Will the recent negative trend continue leading up to its next earnings release or is ImmunoGen due for a breakout Before we

Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More

03/06/19
Mergers and acquisitions continue to grab headlines in the biotech sector Shares of Nightstar Therapeutics NITE soared after Biogen BIIB announced an agreement to acquire the former Meanwhile as the reporting cycle draws to a close regular pipeline updates and data read outs are also in

Immunogen Ovarian Cancer Drug Fails in Phase III, Stock Sinks

03/05/19
Shares of ImmunoGen Inc IMGN fell almost 47 after its ovarian cancer candidatefailed to meet the primary endpoint of progression free survival PFS in a phase III study The FORWARD 1 study evaluated the efficacy of mirvetuximab soravtansine as a single agent therapy compared to

After Hours Most Active for Mar 4, 2019 : LTHM, LLY, ATVI, BAC, S, OHI, GE, GILD, CMCSA, IMGN, AAPL, SGMS

03/04/19
The NASDAQ 100 After Hours Indicator is down 5 81 to 7 145 02 The total After hours volume is currently 64 985 450 shares traded The following are the most active stocks for the after hours session Livent Corporation LTHM is 0 23 at 12 35 with 9 655 952

Mid-Afternoon Market Update: Crude Oil Down 2.5%; Nutanix Shares Plunge On Weak Forecast

03/01/19
Toward the end of trading Friday the Dow traded up 0 49 percent to 26 043 91 while the NASDAQ climbed 0 91 percent to 7 601 26 The S amp P also rose gaining 0 68 percent to 2 803 35 Leading and Lagging Sectors Friday afternoon the health care shares rose 1 2 percent

Health Care Sector Update for 03/01/2019: BIO,MRSN,PBYI,IMGN

03/01/19
Top Health Care StocksTop Health Care Stocks JNJ 0 35 JNJ 0 35 PFE 0 39 PFE 0 39 ABT 0 31 ABT 0 31 MRK 0 16 MRK 0 16 AMGN 0 41 AMGN 0 41 Health care stocks outpacing other sectors Friday gaining strength this afternoon as the broader U S markets faltered At last look the

Mid-Day Market Update: Puma Biotechnology Climbs Following Strong Q4 Results; Intrexon Shares Slide

03/01/19
Midway through trading Friday the Dow traded down 0 01 percent to 25 914 55 while the NASDAQ climbed 0 12 percent to 7 541 22 The S amp P also rose gaining 0 12 percent to 2 787 79 Leading and Lagging Sectors On Friday the energy shares rose 1 1 percent Meanwhile top gainers

Why ImmunoGen Stock Is Crashing Today

03/01/19
What happened Shares of ImmunoGen NASDAQ IMGN are crashing today down by 45 9 as of 11 31 a m EST after the biotech announced disappointing news from its Forward I phase 3 clinical study evaluating mirvetuximab soravtansine 160 in treating ovarian cancer

Health Care Sector Update for 03/01/2019: MRSN,PBYI,IMGN

03/01/19
Top Health Care StocksTop Health Care Stocks JNJ 0 81 JNJ 0 81 PFE 0 07 PFE 0 07 ABT 0 95 ABT 0 95 MRK 0 50 MRK 0 50 AMGN 0 67 AMGN 0 67 Health care stocks were outpacing the broader U S markets this afternoon including a 1 1 gain for the NYSE Health Care Index Shares of

Mid-Morning Market Update: Markets Open Higher; Foot Locker Beats Q4 Estimates

03/01/19
Following the market opening Friday the Dow traded up 0 62 percent to 26 076 22 while the NASDAQ climbed 0 66 percent to 7 582 01 The S amp P also rose gaining 0 7 percent to 2 803 91 Leading and Lagging Sectors Friday morning the financial shares rose 1 3 percent Meanwhile

Health Care Sector Update for 03/01/2019: IMGN, MRSN, PBYI, JNJ, PFE, MRK, ABT, AMGN

03/01/19
Top Health Care Stocks Top Health Care Stocks JNJ 0 26 JNJ 0 26 PFE 0 37 PFE 0 37 ABT FlatABT Flat MRK FlatMRK Flat AMGN FlatAMGN Flat Friday pre bell saw flat to higher health care majors Friday pre bell saw flat to higher health care majors Stocks moving on news include

Pre-Market Most Active for Mar 1, 2019 : IMGN, GRPN, GPS, FL, AMD, SQQQ, GE, ERIC, QQQ, CHK, VIPS, NIO

03/01/19
The NASDAQ 100 Pre Market Indicator is up 33 93 to 7 131 46 The total Pre Market volume is currently 13 859 901 shares traded The following are the most active stocks for the pre market session ImmunoGen Inc IMGN is 2 27 at 2 45 with 3 281 764 shares traded

Why ImmunoGen Tumbled 20.3% Today

02/28/19
What happened Investors reined in risk Wednesday ahead of data from a phase 3 trial that could support the eventual approval of one of ImmunoGen Inc s NASDAQ IMGN 160 most anticipated drugs and news regarding presentations planned for an upcoming conference Investors